Literature DB >> 2338417

The pharmacokinetics and sputum penetration of ampicillin and amoxycillin following simultaneous i.v. administration.

A M Lovering1, C J Pycock, J E Harvey, D S Reeves.   

Abstract

Five patients with exacerbation of chronic bronchitis received as a single iv injection 500 mg of ampicillin and 500 mg of amoxycillin. Blood and sputum samples were collected at timed intervals following dosing and the concentrations of the two antibiotics present in the samples were determined by HPLC analysis. No statistically significant differences were observed between the serum concentrations of ampicillin and amoxycillin, and the pharmacokinetics of the two drugs were almost identical, with half lives of 93 min (amoxycillin) and 103 min (ampicillin). Sputum amoxycillin concentrations were significantly higher (Student's paired t-test; P less than 0.001) than those of ampicillin, with mean levels two hours after dosing of 2.9 mg/l (range 1.9-4.0) for amoxycillin and 1.4 mg/l (range 0.8-2.4) for ampicillin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2338417     DOI: 10.1093/jac/25.3.385

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  6 in total

Review 1.  New formulations of amoxicillin/clavulanic acid: a pharmacokinetic and pharmacodynamic review.

Authors:  Amparo Sánchez Navarro
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

2.  Liquid Chromatography Mass Spectrometry Detection of Antibiotic Agents in Sputum from Persons with Cystic Fibrosis.

Authors:  Tara Gallagher; Stefan Riedel; Joseph Kapcia; Lindsay J Caverly; Lisa Carmody; Linda M Kalikin; Junnan Lu; Joann Phan; Matthew Gargus; Miki Kagawa; Simon W Leemans; Jason A Rothman; Felix Grun; John J LiPuma; Katrine L Whiteson
Journal:  Antimicrob Agents Chemother       Date:  2021-01-20       Impact factor: 5.191

3.  Penetration of amoxycillin/clavulanic acid into bronchial mucosa with different dosing regimens.

Authors:  I M Gould; G Harvey; D Golder; T M Reid; S J Watt; J A Friend; J S Legge; J G Douglas
Journal:  Thorax       Date:  1994-10       Impact factor: 9.139

4.  The influence of labour on the pharmacokinetics of intravenously administered amoxicillin in pregnant women.

Authors:  Anouk E Muller; P Joep Dörr; Johan W Mouton; Joost De Jongh; Paul M Oostvogel; Eric A P Steegers; Rob A Voskuyl; Meindert Danhof
Journal:  Br J Clin Pharmacol       Date:  2008-12       Impact factor: 4.335

5.  Use of an enzyme-linked immunosorbent assay to assess penetration of amoxicillin into lung secretions.

Authors:  S L Hill; D Burnett; A L Lovering; R A Stockley
Journal:  Antimicrob Agents Chemother       Date:  1992-07       Impact factor: 5.191

6.  Amoxicillin concentrations in relation to beta-lactamase activity in sputum during exacerbations of chronic obstructive pulmonary disease.

Authors:  Marjolein Brusse-Keizer; Paul VanderValk; Rogier W van der Zanden; Lars Nijdam; Job van der Palen; Ron Hendrix; Kris Movig
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-03-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.